214903-69-2

Upstream product

• 68502-22-7 3-amino-4-benzylamine-benzoic acid methyl ester 
• 530-62-1 1,1'-carbonyldiimidazole 
• 96-99-1 4-chloro-3-nitrobenzoate 
• 100-46-9 benzylamine 
• 14719-83-6 methyl 3-nitro-4-chlorobenzoate 
• 68502-46-5 4-benzylamine-3-nitro-benzoic acid methyl ester 

Downstream Products

• 1646359-33-2 1-benzyl-2-oxo-3-methyl-2,3-dihydro-1H-benzimidazole-5-carboxylic acid methyl ester 
• 214903-72-7 1-Benzyl-2-(4-methyl-piperazin-1-yl)-1H-benzoimidazole-5-carboxylic acid methyl ester 
• 214903-73-8 1-Benzyl-2-(4-methyl-piperidin-1-yl)-1H-benzoimidazole-5-carboxylic acid methyl ester 
• 214903-78-3 1-Benzyl-2-(4-methyl-piperazin-1-yl)-1H-benzoimidazole-5-carboxylic acid 
• 214903-75-0 1-Benzyl-2-(4-methyl-piperidin-1-yl)-1H-benzoimidazole-5-carboxylic acid 
• 100440-64-0 1-Benzyl-2-chloro-1H-benzoimidazole-5-carboxylic acid methyl ester 

Relevant academic research and scientific papers

Synthesis and bioevaluation of pyrazole-benzimidazolone hybrids as novel human 4-Hydroxyphenylpyruvate dioxygenase inhibitors

4-Hydroxyphenylpyruvate dioxygenase (HPPD), an essential enzyme in tyrosine catabolism, is an important target for treating type I tyrosinemia. Inhibition of HPPD can effectively alleviate the symptoms of type I tyrosinemia. However, only one commercial H

Synthesis of some new benzimidazolecarboxamides and evaluation of their antimicrobial activity

A series of 1,2-disubstituted benzimidazole-5(6)-carboxamides was prepared and evaluated in vitro for antimicrobial activity against Staphyloccus aureus, Escherichia coli and Candida albicans. The precursor benzimidazolecarboxylic acids 4a-c and 9a-c were